17.05.2014 03:00:00

Abbott Laboratories -- Moody's: Abbott's acquisition of CFR Pharmaceuticals is credit positive; ratings unaffected

New York, May 16, 2014 -- Moody's Investors Service said that Abbott Laboratories' (A1 negative) announced acquisition of CFR Pharmaceuticals S.A. (not rated), a Chilean branded generic pharmaceutical company, is credit positive but has no effect on Abbott's ratings or outlook. For further information, please see Moody's Issuer Comment on Abbott on www.moodys.com.

Vollständigen Artikel bei Moodys lesen